Peanut anaphylaxis in 2022: Decoupling epinephrine usage from emergency department evaluation.

Winslow, Andrew; Gilmore, Alexander; Kim, Edwin H

Winslow, Andrew; Gilmore, Alexander; Kim, Edwin H.

Winslow A; Division of Allergy and Immunology, Department of Pediatrics, The University of North Carolina Chapel Hill, Chapel Hill, North Carolina. Electronic address: andrew.winslow@unc.edu.
Gilmore A; Division of Allergy and Immunology, Department of Pediatrics, The University of North Carolina Chapel Hill, Chapel Hill, North Carolina.
Kim EH; Division of Allergy and Immunology, Department of Pediatrics, The University of North Carolina Chapel Hill, Chapel Hill, North Carolina.

Ann Allergy Asthma Immunol ; 129(3): 382-384, 2022 09.

Article in English | MEDLINE | ID: covidwho-1894774

Subject(s)

Anaphylaxis; Peanut Hypersensitivity; Anaphylaxis/drug therapy; Arachis; Emergency Service, Hospital; Epinephrine/therapeutic use; Humans; Peanut Hypersensitivity/drug therapy

Fulltext

XML

PubMed Links

Search on Google

Full text: Available Collection: International databases Database: MEDLINE Main subject: Peanut Hypersensitivity / Anaphylaxis Type of study: Experimental Studies Limits: Humans Language: English Journal: Ann Allergy Asthma Immunol Journal subject: Allergy and Immunology Year: 2022 Document Type: Article

Similar

MEDLINE

LILACS

LIS

Fulltext

XML

PubMed Links

Search on Google